Advertisement
Articles
Subscribe to Drug Discovery & Development Articles

The Lead

Meet Thomas Goetz, The Co-founder of Iodine

March 5, 2015 | by Ryan Bushey, Associate Editor | Comments

The startup has been called "The Yelp of Medicine." Read more...                                                         

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Increased Use of Tissue Data in Oncology: Enhancing Diagnostics, Cutting Costs & Improving Patient Lives

March 3, 2015 10:43 am | by Ralf Huss, MD, Chief Medical Officer, Definiens | Comments

New research by market research firm Frost & Sullivan revealed that the increased use of clinical tools such as in vitro tissue analysis, biomarker tests and cancer screening are causing oncologic imaging to shift away from invasive to non- or minimally-invasive methods, which can result in better real-time monitoring of tumors without damaging tissues. Read more...

TOPICS:

Making Proactive Asset Management Work for Business

February 27, 2015 1:02 pm | by Ben Potenza, VP Marketing, EquipNet | Comments

Millions are spent every year on the laboratory equipment and instrumentation that is essential for the daily work of research and analysis in the pharmaceutical, biotechnology and chemical sectors. Read more...                 

TOPICS:

Hair Cells From Stem Cells

February 25, 2015 10:23 am | by Drug Discovery & Development Staff | Comments

In a research area that will generate blockbuster profits if/when it pans out, a science team reported creating new hair cells from pluripotent stem cells in a recent issue of PLOS (Proceedings of the Library of Science) One. Read more..

TOPICS:
Advertisement

Improving Patient Onboarding with Advancements in Medical Device Training

February 23, 2015 10:48 am | by Craig Baker, Executive Vice President, Noble | Comments

For some patients diagnosed with chronic medical conditions, weekly or biweekly self-administration using drug delivery devices is often a necessary component of a successful treatment program. Read more...

TOPICS:

The Journey to an HIV Vaccine Endures

February 19, 2015 12:46 pm | by Stephanie Guzowski, Editor | Comments

Despite more than 30 years of efforts, scientists have not yet come up with a reliably effective HIV vaccine — in part, because of the inherently complicated nature of the virus. Here are where their research efforts stand today.

TOPICS:

Closing the Knowledge Gap on Cancer Drug Toxicity

February 12, 2015 3:59 pm | by David Jackson, Ph.D., Chief Innovation Officer, MolecularHealth | Comments

There is a dangerous knowledge gap in the use of cancer medications that needs to be closed, immediately. Read more...                                                          

TOPICS:

Science is Afire With Plans to Help Smokers Quit

February 12, 2015 12:25 pm | by Cynthia Fox, Science Editor | Comments

All types of scientists are at work, on all kinds of quit-smoking aids, from an anti-smoking vaccine to a biomarker test. Read more...                                         

TOPICS:

Stem Cells Boost Cognition Following Cancer Radiation: Studies

February 10, 2015 2:13 pm | by Cynthia Fox, Science Editor | Comments

A solid run of preclinical work is finding that human stem cell transplants can significantly—and in some cases, completely—restore cognitive and motor deficits associated with cancer irradiation in animal models. Read more...                           

TOPICS:
Advertisement

Reducing Animal Testing One Chip at a Time

February 10, 2015 9:19 am | by Michelle Taylor, Editor-in-Chief, Lab Equipment | Comments

Speaking to a room of pharmaceutical scientists, Donald Ingber started off his Keynote presentation at SLAS 2015 in Washington D.C. by saying that “the current drug development model is broken.” He pointed to Eroom’s Law (Moore’s law backward) as proof. Read more...

TOPICS:

CDK4/6 Inhibitor: Promising Results for Treating Breast Cancer

February 9, 2015 1:06 pm | by Drug Discovery & Development staff | Comments

The words “exciting,” “breakthrough,” and “standard-of-care-changing” are being used with regard to cyclin-dependent kinase (CDK) 4 and 6 inhibitors and metastatic breast cancer. Read more...                                       

TOPICS:

Meet the New ACS CEO: Tom Connelly

February 6, 2015 4:33 pm | by Michelle Taylor, Editor-in-Chief, Laboratory Equipment | Comments

Come February 17, Thomas M. Connelly, Jr. will be the new CEO of the American Chemical Society (ACS), taking over for Madeleine Jacobs, who is retiring after 11 years as CEO and a total of 24 years with ACS. Connelly talks about the challenges the chemistry industry faces today. Read more... 

TOPICS:

Reversing the Global Diabesity Epidemic

February 6, 2015 1:42 pm | by Suzanne Tracy, Editor-in-Chief, Scientific Computing and HPC Source | Comments

Diabesity has been identified as a major global health problem by researchers and healthcare professionals world-wide, including England’s National Health Service, Brigham and Women’s Hospital and Harvard Medical School, Ain Shams University Hospital in Cairo, Egypt, and a research consortium of the European Union. Read more...

TOPICS:

The Longevity of Attention Deficit Drugs

February 5, 2015 5:09 pm | by Stephanie Guzowski, Editor | Comments

Can A.D.H.D. drugs help “normalize“ a child’s brain? Recent research suggests that A.D.H.D. medication may regulate the brain over time, rewiring neural connections, so that the focus and in-control effect endures. Read more...

TOPICS:

Most Popular Books by Scientists in 2014

February 4, 2015 8:46 am | by Drug Discovery & Development staff | Comments

Books by scientists that made popular magazine and blog “Best Of” lists in 2014 ranged widely in topics, from death to DNA to the sardine-scented docks trodden by Aristotle. Read more...                       

TOPICS:

Needle Biopsies May Be Safe in Pancreatic Cancer

January 29, 2015 4:06 pm | by Cynthia Fox, Science Editor | Comments

Oncologists and patients who fear tumor needle biopsies—thinking they may cause tumor bits to break off and “seed” cancer elsewhere—may rest easier after reassuring Mayo Clinic news. Read more...                   

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading